Extensively drug-resistant tuberculosis (XDR-TB), which is TB resistant to isoniazid and rifampin plus one fluoroquinolone and a second-line injectable drug, represents an obstacle for the treatment and control of TB. Previously, we reported four XDR-TB cases and a high proportion of the Beijing
